124 related articles for article (PubMed ID: 17165073)
1. Resource use and costs associated with patients treated for depression in primary care.
Sobocki P; Ekman M; Agren H; Krakau I; Runeson B; Mårtensson B; Jönsson B
Eur J Health Econ; 2007 Mar; 8(1):67-76. PubMed ID: 17165073
[TBL] [Abstract][Full Text] [Related]
2. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
3. Costs and quality of life for patients with multiple sclerosis in Belgium.
Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
[TBL] [Abstract][Full Text] [Related]
4. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
5. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
6. Costs and quality of life of multiple sclerosis in Spain.
Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
[TBL] [Abstract][Full Text] [Related]
7. Costs and quality of life of multiple sclerosis in Sweden.
Berg J; Lindgren P; Fredrikson S; Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
[TBL] [Abstract][Full Text] [Related]
8. The economic burden of depression in Switzerland.
Tomonaga Y; Haettenschwiler J; Hatzinger M; Holsboer-Trachsler E; Rufer M; Hepp U; Szucs TD
Pharmacoeconomics; 2013 Mar; 31(3):237-50. PubMed ID: 23417609
[TBL] [Abstract][Full Text] [Related]
9. [The social cost of depression in the city of Sabadell (Barcelona, Spain) (2007-2008)].
Pamias Massana M; Crespo Palomo C; Gisbert Gelonch R; Palao Vidal DJ
Gac Sanit; 2012; 26(2):153-8. PubMed ID: 22055213
[TBL] [Abstract][Full Text] [Related]
10. The societal cost of depression: evidence from 10,000 Swedish patients in psychiatric care.
Ekman M; Granström O; Omérov S; Jacob J; Landén M
J Affect Disord; 2013 Sep; 150(3):790-7. PubMed ID: 23611536
[TBL] [Abstract][Full Text] [Related]
11. Direct costs associated with depressive symptoms in late life: a 4.5-year prospective study.
Luppa M; König HH; Heider D; Leicht H; Motzek T; Schomerus G; Riedel-Heller SG
Int Psychogeriatr; 2013 Feb; 25(2):292-302. PubMed ID: 23083505
[TBL] [Abstract][Full Text] [Related]
12. Costs and quality of life of multiple sclerosis in Germany.
Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
[TBL] [Abstract][Full Text] [Related]
13. Cost of breast cancer in Sweden in 2002.
Lidgren M; Wilking N; Jönsson B
Eur J Health Econ; 2007 Mar; 8(1):5-15. PubMed ID: 17216424
[TBL] [Abstract][Full Text] [Related]
14. The societal cost of schizophrenia in Sweden.
Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
[TBL] [Abstract][Full Text] [Related]
15. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.
Iskrov G; Astigarraga I; Stefanov R; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Schieppati A; Taruscio D; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():67-78. PubMed ID: 27042831
[TBL] [Abstract][Full Text] [Related]
16. Health care costs of primary care patients with recognized depression.
Simon GE; VonKorff M; Barlow W
Arch Gen Psychiatry; 1995 Oct; 52(10):850-6. PubMed ID: 7575105
[TBL] [Abstract][Full Text] [Related]
17. Resource use and economic impact of patients with gout: a multicenter, population-wide study.
Sicras-Mainar A; Navarro-Artieda R; Ibáñez-Nolla J
Reumatol Clin; 2013; 9(2):94-100. PubMed ID: 23313534
[TBL] [Abstract][Full Text] [Related]
18. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.
López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Baji P; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():99-108. PubMed ID: 27038627
[TBL] [Abstract][Full Text] [Related]
19. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
20. What does treatment of depression really cost?
Croghan TW; Obenchain RL; Crown WE
Health Aff (Millwood); 1998; 17(4):198-208. PubMed ID: 9691563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
